Overview
- 3 inspections across 3 sites are on record.
- 3 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2015-08-05.
At a glance
Inspections
3
Sites
3
Observations
3
Career since
Nov 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc. | 5 Aug 2015 | Human Drugs | |
| Azur Pharma, Inc. | 1 Apr 2011 | ||
| Express Scripts Specialty Distribution Services Inc | 5 Nov 2009 |
Sites inspected
Teva Pharmaceuticals USA Inc.Overland Park, United States1 insp.
Azur Pharma, Inc.Philadelphia, United States1 insp.
Express Scripts Specialty Distribution Services IncSaint Louis, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Kendra A Biddick's 3 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site